open access

Vol 86, No 4 (2015)
ARTICLES
Get Citation

Expression of melatonin receptors genes and genes associated with regulation of their activity in endometrial cancer

Andrzej Witek, Agnieszka Jęda, Michał Baliś, Joanna Orchel, Bartosz Sikora, Aleksandra Skubis, Justyna Szota-Czyż, Tomasz Janikowski, Urszula Mazurek
DOI: 10.17772/gp/2069
·
Ginekol Pol 2015;86(4).

open access

Vol 86, No 4 (2015)
ARTICLES

Abstract

Objectives: The aim of the study was to evaluate transcription activity of melatonin receptors and genes associated with regulation of their activity in endometrial adenocarcinoma to identify probable diagnostic and prognostic molecular markers. Material and methods: The material included endometrial adenocarcinoma tissue samples of histopathological grades G1, G2, G3, and normal endometrium. The molecular analysis was performed on 37 patient samples. Total RNA was extracted and used for the microarray HG-U133A analysis. Among 22 283 ID mRNA, only entities of genes associated with regulation of melatonin receptors activity were selected. qRT-PCR was employed for validation, what allowed to compare melatonin receptor genes activation in endometrial cancer tissues to the normal endometrium. Results: The results of the microarray experiments showed that only 18 ID mRNA were differential in endometrial cancer samples as compared to the control at p-value<0.05 and FC(log2)>1.5. These genes were identified as differentially expressed in grade G2- ASMTL, GNA11, PER2, PTGDS and in grade G3- GNAI2, GNA11. Silencing of RGS4 encoding RGP4, which regulates signal transmission by G protein, was observed in all cancer groups, independently of the histopathological grade. Conclusions: The profile expression of genes associated with regulation of melatonin receptors activity was different and dependent on the histopathological grade of endometrial cancer and can be an additional diagnostic and prognostic marker. Statistically significant was the down-regulation of melatonin biosynthesis genes (ASMTL) and melatonin signal transmitters (GNA11, GNA12, RTGS

Abstract

Objectives: The aim of the study was to evaluate transcription activity of melatonin receptors and genes associated with regulation of their activity in endometrial adenocarcinoma to identify probable diagnostic and prognostic molecular markers. Material and methods: The material included endometrial adenocarcinoma tissue samples of histopathological grades G1, G2, G3, and normal endometrium. The molecular analysis was performed on 37 patient samples. Total RNA was extracted and used for the microarray HG-U133A analysis. Among 22 283 ID mRNA, only entities of genes associated with regulation of melatonin receptors activity were selected. qRT-PCR was employed for validation, what allowed to compare melatonin receptor genes activation in endometrial cancer tissues to the normal endometrium. Results: The results of the microarray experiments showed that only 18 ID mRNA were differential in endometrial cancer samples as compared to the control at p-value<0.05 and FC(log2)>1.5. These genes were identified as differentially expressed in grade G2- ASMTL, GNA11, PER2, PTGDS and in grade G3- GNAI2, GNA11. Silencing of RGS4 encoding RGP4, which regulates signal transmission by G protein, was observed in all cancer groups, independently of the histopathological grade. Conclusions: The profile expression of genes associated with regulation of melatonin receptors activity was different and dependent on the histopathological grade of endometrial cancer and can be an additional diagnostic and prognostic marker. Statistically significant was the down-regulation of melatonin biosynthesis genes (ASMTL) and melatonin signal transmitters (GNA11, GNA12, RTGS
Get Citation

Keywords

melatonin / melatonin receptors / endometrial adenocarcinoma / / estrogen-dependent malignancies / estrogens /

About this article
Title

Expression of melatonin receptors genes and genes associated with regulation of their activity in endometrial cancer

Journal

Ginekologia Polska

Issue

Vol 86, No 4 (2015)

DOI

10.17772/gp/2069

Bibliographic record

Ginekol Pol 2015;86(4).

Keywords

melatonin / melatonin receptors / endometrial adenocarcinoma / / estrogen-dependent malignancies / estrogens /

Authors

Andrzej Witek
Agnieszka Jęda
Michał Baliś
Joanna Orchel
Bartosz Sikora
Aleksandra Skubis
Justyna Szota-Czyż
Tomasz Janikowski
Urszula Mazurek

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

By "Via Medica sp. z o.o." sp.k., ul. Świętokrzyska 73, 80–180 Gdańsk
tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail:  viamedica@viamedica.pl